Stay updated on Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Locations section updated to include New York and Wisconsin as study sites. Location subsections were reorganized under a new Locations header.
    Difference
    0.3%
    Check dated 2025-12-23T09:45:43.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2 instead of v3.3.1; there are no visible changes to the study details or layout.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:20.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.2.0 to v3.3.1. The change does not modify study details, eligibility criteria, or results information.
    Difference
    0.1%
    Check dated 2025-11-24T13:07:40.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Removed a general government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:25:26.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The related topics Prostate cancer and MedlinePlus Genetics were removed from the page. The primary study details, design, and locations remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-10T03:36:27.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    Added 'Prostate cancer' and 'related topics: MedlinePlus Genetics' to the page's related topics. This is a minor metadata update that does not alter core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-03T01:06:51.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.